Micro-invasive surgery for glaucoma treatment
NorMIGS - a Prospective Study of Micro-invasive Glaucoma Surgery
This study is testing a new micro-surgery for glaucoma to see if it works better and has fewer problems than traditional surgeries for patients needing treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Trial ID | NCT05340647 on ClinicalTrials.gov |
What this trial studies
NorMIGS is an observational study that evaluates the effectiveness and complications of the Preserflo microshunt implantation compared to other glaucoma surgeries, such as trabeculectomy. Conducted at the Department of Ophthalmology at Oslo University Hospital, the study aims to gather data on intraocular pressure reduction and patient outcomes. Participants will be monitored for their ability to cooperate during examinations and provide informed consent. The study includes patients scheduled for various types of glaucoma surgery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are scheduled for implantation of the Preserflo microshunt, trabeculectomy, or other micro-invasive glaucoma surgeries.
Not a fit: Patients with high intraocular pressure due to conditions like hemorrhagic glaucoma, traumatic glaucoma, or uveitis glaucoma may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into safer and more effective surgical options for glaucoma patients.
How similar studies have performed: Other studies have shown promising results with micro-invasive glaucoma surgeries, indicating that this approach is gaining traction in the field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit. * Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS * Ability to cooperate fairly well during the examinations * Willing to participate in the study and capable of providing informed consent Exclusion Criteria: \- High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma
Where this trial is running
Oslo
- Department of Ophthalmology, Oslo University Hospital — Oslo, Norway (Recruiting)
Study contacts
- Principal investigator: Olav Kristianslund, MD PhD — Department of Ophthalmology, Oslo University Hospital
- Study coordinator: Olav Kristianslund, MD PhD
- Email: olakri@ous-hf.no
- Phone: +4722118545
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.